Robust Growth Forecast for Orthopedic Trauma Devices Market

Traffic accidents and sports injuries are expected to drive growth of the orthopedic trauma devices sector through 2028, according to data from Future Market Insights.

The market research firm anticipates the sector to expand 6.8 percent annually over the next six years to top $14 billion in value. Contributing to the growth will be the impactful presence of some local players within respective regional markets.
 
“While the advent of 3D printing technology is likely to present the market a heap of new growth opportunities in 3D printed orthopedic implants, another significant opportunities lies in the popularly trending reverse shoulder arthroplasty. The rise of digital orthopedics will continue to fuel market growth through to 2028,” a research analyst at ESOMAR-certified market research stated.
 
Based on the regional analysis, North America will continue to dominate the global orthopedic trauma devices market (it currently accounts for a major portion of total revenue). With about 48 percent value share observed in 2021, the North American market is estimated to be worth more than $6 billion by the end of 2028. Western Europe holds the second largest market share but manufacturers will discover attractive opportunities in developing economies, including Asia Pacific, Latin America, and Middle East and Africa. Among the emerging regional markets, Asia Pacific—excluding China and Japan (APECJ)—is likely to emerge at a relatively higher pace, followed by MEA. China is expected to be the most lucrative market, owing to the highest estimated compound annual growth rate through2028. The presence of key companies will reportedly uplift the North American and Chinese markets.
 
A majority of the key companies operating in the orthopedic trauma market are opting for strategic mergers and acquisitions, in addition to new product launches. According Future Market Insights’ report, most of the revenue is contributed by the tier 1 companies, followed by the tier 3 players. The tier 1 firms include DePuy Synthes Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., and Smith & Nephew Plc., which collectively represent nearly 70 percent share of the total market revenues. Among these, DePuy and Stryker will continue to remain the top players worldwide over the next decade. Tier 3 accounts for a relatively decent revenue share and includes brands such as Arthrex Inc., RTISurgical, Medartis, Integra LifeSciences Corporation, Japan MDM, S. H. Pitkar Orthotools Pvt. Ltd, Weigao Group Co. Ltd., and Invibio Ltd.
 
Others operating in the global orthopedic trauma devices market include Johnson & Johnson Services Inc., Wright Medical Group NV, B. Braun Melsungen AG, Orthofix International, and OsteoMed. Growing outpatient surgical procedure demand and boosting funds for delivery of the top-notch trauma care are foreseen to collectively create a lucrative pool of opportunities for the leading bunch of companies in the global marketplace. The market is also witnessing the development of novel and effective products for use in trauma care, which stands to be another important opportunity.